Mitoxantrone Completed Phase 1 Trials for Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00024492Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer